Mediktor Underpins its Growth in America and Japan with New Agreements

Mediktor advances positions in the international arena. The Spanish digital health company has sealed different agreements to bring its artificial intelligence (AI) technology for triage and pre-diagnosis in Puerto Rico and Japan.

Read more about Mediktor and find other important business news from around the world, with our companion app Born2Invest.

The first of the agreements that Mediktor has signed is with the Puerto Rican company Telemedik

The Latin American company draws on the Spanish service to reach its customers. The solution aims to provide accurate triage of information prior to consultation. The tool consists of an analysis of the symptoms that makes it possible to assess the state of health of a patient and redirect him to the most appropriate specialist with a considerable reduction in time and without unnecessary travel.

This service is automated but ensures individualized follow-up by a professional to ensure that a unique experience is provided during a vulnerable moment such as feeling sick. The user can access this solution through different channels.

Mediktor signed Amit Jain as president of the United States last year

Without leaving America, Mediktor is also looking to grow on American soil. To do this, the company has just appointed Fred Pineiro as the new chief growth officer in the country. Pineiro has previous experience in companies such as Oracle, Kronos, and Cerner Corporation.

Precisely in the United States, last year Mediktor incorporated Amit Jain, an experienced manager, as its new president. Jain has over 25 years of experience in the healthcare industry. Previously, the manager had served as CEO of AppianRx and as managing partner at Frazier Healthcare Partners. He has also worked at Omnicare and Genpact.

The Spanish digital health company has already had experience in the United States, such as an agreement with Yale University and its hospital centers, as well as the Austin Regional Clinic.

In Japan, the company has reached an agreement with the insurance company AXA

In Japan, Mediktor has sealed an agreement with the insurer AXA, through which, the Spanish company provides a web service to policyholders in the Japanese country related to pre-diagnosis and health prevention.

Mediktor, based in the Recinto Modernista de Sant Pau in Barcelona, ​​operates a B2B model and offers software as a service  (SaaS) for insurance companies, hospitals, telemedicine, and pharmaceutical platforms. The company currently has offices in the Catalan capital and in Brooklyn, New York (United States).

The company was created in 2011  and was founded by Oscar García-Esquirol, an intensive care doctor, and Cristian Pascual, an industrial engineer. They developed a white-label SasS software ready to be integrated into any interface. The medical assistant generates a recommendation on the most appropriate care available after evaluating the patient’s symptoms.

Mediktor closed a financing round of $13 million at the end of 2021  to continue improving its technology and expand its team and its international presence. The round was led by the Mtip fund and also received the support of Alta LS.

__

(Featured image by Tumisu via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in PlantaDoce. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.